Exact Mass: 266.1602
Exact Mass Matches: 266.1602
Found 500 metabolites which its exact mass value is equals to given mass value 266.1602,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
TRIBUTYL PHOSPHATE
D020011 - Protective Agents > D011837 - Radiation-Protective Agents
Practolol
Practolol is only found in individuals that have used or taken this drug. It is a beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. [PubChem]Like other beta-adrenergic antagonists, practolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, practolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Same as: D05587 Practolol is a potent and selective β1-adrenergic receptor antagonist. Practolol can be used for the research of cardiac arrhythmias[1][2][3].
atenolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; INTERNAL_ID 4076 CONFIDENCE Reference Standard (Level 1) CONFIDENCE standard compound; INTERNAL_ID 1106 Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].
Atenolol
Atenolol is a so-called beta1-selective (or cardioselective) drug. That means that it exerts greater blocking activity on myocardial beta1-receptors than on beta2 ones in the lung. The beta2 receptors are responsible to keep the bronchial system open. If these receptors are blocked, bronchospasm with serious lack of oxygen in the body can result. However, due to its cardioselective properties, the risk of bronchospastic reactions if using atenolol is reduced compared to nonselective drugs as propranolol. Nonetheless, this reaction may also be encountered with atenolol, particularly with high doses. Extreme caution should be exerted if atenolol is given to asthma patients, who are particularly at risk; the dose should be as low as possible. If an asthma attack occurs, the inhalation of a beta2-mimetic antiasthmatic, such as hexoprenalin or salbutamol, will usually suppress the symptoms.; Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases such as hypertension, coronary heart disease, arrhythmias, and treatment of myocardial infarction after the acute event. Patients with compensated congestive heart failure may be treated with atenolol as a co medication (usually together with an ACE inhibitor, a diuretic and a digitalis-glycoside, if indicated). In patients with congestive heart failure, it reduces the need for and the consumption of oxygen of the heart muscle. It is very important to start with low doses, as atenolol reduces also the muscular power of the heart, which is an undesired effect in congestive heart failure. [HMDB] Atenolol is a so-called beta1-selective (or cardioselective) drug. That means that it exerts greater blocking activity on myocardial beta1-receptors than on beta2 ones in the lung. The beta2 receptors are responsible to keep the bronchial system open. If these receptors are blocked, bronchospasm with serious lack of oxygen in the body can result. However, due to its cardioselective properties, the risk of bronchospastic reactions if using atenolol is reduced compared to nonselective drugs as propranolol. Nonetheless, this reaction may also be encountered with atenolol, particularly with high doses. Extreme caution should be exerted if atenolol is given to asthma patients, who are particularly at risk; the dose should be as low as possible. If an asthma attack occurs, the inhalation of a beta2-mimetic antiasthmatic, such as hexoprenalin or salbutamol, will usually suppress the symptoms. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases such as hypertension, coronary heart disease, arrhythmias, and treatment of myocardial infarction after the acute event. Patients with compensated congestive heart failure may be treated with atenolol as a co medication (usually together with an ACE inhibitor, a diuretic and a digitalis-glycoside, if indicated). In patients with congestive heart failure, it reduces the need for and the consumption of oxygen of the heart muscle. It is very important to start with low doses, as atenolol reduces also the muscular power of the heart, which is an undesired effect in congestive heart failure. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].
(3xi,6E)-1,7-Diphenyl-6-hepten-3-ol
(3xi,6E)-1,7-Diphenyl-6-hepten-3-ol is found in beverages. (3xi,6E)-1,7-Diphenyl-6-hepten-3-ol is a constituent of seeds of Curcuma xanthorrhiza (Java turmeric)
Bucolome
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
CC(=O)Nccccccn1C=CC(=O)C(O)=C1C
Dilatan
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
atenolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 169 Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].
1beta,10alpha-Dihydroxy-11(13)-eremophilen-12,8beta-olide
5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)octan-3-one
Grangolide
1beta,9beta-Dihydroxycostic acid
10alpha,14-Epoxy-3beta-hydroxy-12,6alpha-guaianolide
3alpha-Hydroxy-1beta,10beta-epoxy-11betaH-eremophilan-12,8beta-olide
Arbusculin D
8beta,9beta-Dihydroxycostic acid
[3aR-(3aalpha,4aalpha,5alpha,8alpha,8abeta,9aalpha)]-Decahydro-5,8-dihydroxy-5,8a-dimethyl-3-methylene-naphtho[2,3-b]furan-2(3H)-one
[3S-(3alpha,3abeta,4abeta,8aalpha,9abeta)]-Decahydro-3a-hydroperoxy-3,8a-dimethyl-5-methylenenaphtho[2,3-b]furan-2(3H)-one
Curvularol
An organic heterotricyclic compound that is isolated from the fermentation broth of Curvularia sp. RK97-F166. D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Isogallicadiol
1-Epiartemin
1-Epialkhanol
9beta-Hydroxy-4beta,11alpha,13,15-tetrahydrozaluzanin C
[3R-(3alpha,3abeta,6alpha,6abeta,9abeta,9balpha)]-Decahydro-6-hydroxy-6-(hydroxymethyl)-3-methyl-9-methylene-azuleno[4,5-b]furan-2(3H)-one
2,2,4,4-Tetramethyl-6-(2-methyl-1-oxobutyl)-1,3,5-cyclohexanetrione
8-methoxy-9-O-isobutyrylthymol
A natural product found in Eupatorium cannabinum subspecies asiaticum.
Lauryl sulfate
D013501 - Surface-Active Agents Annotation level-3 CONFIDENCE standard compound; INTERNAL_ID 2407 CONFIDENCE standard compound; INTERNAL_ID 4066 CONFIDENCE standard compound; INTERNAL_ID 8761
TRIISOBUTYL PHOSPHATE
CONFIDENCE standard compound; INTERNAL_ID 2468 CONFIDENCE standard compound; INTERNAL_ID 8808 CONFIDENCE standard compound; INTERNAL_ID 8248 CONFIDENCE standard compound; INTERNAL_ID 4188
TRIMETAZIDINE
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(4aR,5S)-9,9a-dihydroxy-3,4a,5-trimethyl-5,6,7,8,8a,9-hexahydro-4H-benzo[f][1]benzofuran-2-one
STROBILACTONE A
4beta,10beta-dihydroxy-1alpha(H),5alpha(H)-guai-11(13)-en-8alpha,12-olide
(11R)-11,13-dihydrotatridin-B|11,12-dihydrotatridin B
8,9-dihydroxy-3,9-dimethyl-6-methylenedecahydroazuleno[4,5-b]furan-2(3h)-one
1??,4??-Epoxy-5??-hydroxy-10??H-xantha-11(13)-en-12,8??-olide
5alpha,9beta-dihydroxyeudesm-4(15),11(13)-dien-12-oic acid
(1alpha,1aalpha,2beta,3beta,7alpha,7aalpha,7balpha)-1,1a,2,3,6,7,7a,7b-octahydro-2,3-dihydroxy-1-(hydroxymethyl)-1,7,7a-trimethyl-5H-cyclopropa[a]naphthalen-5-one|rulepidatriol
6beta,10beta-dihydroxyeremophil-7(11)-en-12,8alpha-olide
3alpha,6alpha-dihydroxy-8alphaH-7(11)-eremophilen-12,8-olide
O1-Me,O3-(3-methyl-2-butenyl)-3,5-Dihydroxy-4-methyl-1,2-benzenedimethanol
(3R,4S,5R,10S,11S)-3-hydroxy-8-oxo-6-eremophilen-12-oic acid
2alpha,5alpha-dihydroxy-11alpha(H)-eudesma-4(15)-en-8beta,12-olide|2alpha,5alpha-dihydroxy-11alphaH-eudesm-4(15)-en12,8beta-olide|2alpha,5alpha-dihydroxy-11alphaH-eudesma-4(15)-en-12,8-beta-olide|2alpha,5alpha-dihydroxy-11alphaH-eudesma-4(15)-en-12,8beta-olide
(3alpha,4alpha,6alpha,11beta)-3-hydroxyguaia-1(10)-eno-12,6-lactone|rel-(3R,3aS,8R,9S,9aS,9bS)-3a,4,5,7,8,9,9a,9b-octahydro-8-hydroxy-6-(hydroxymethyl)-3,9-dimethylazuleno[4,5-b]furan-2(3H)-one
1beta,9beta-dihydroxy-4alphaH-eudesma-5,11(13)-dien-12-oic acid
1,6-Dimethyl-4-isopropyl-5-hydroxy-4,5,6,7-tetrahydro-1,4-ethanocyclopenta[d][1,2]dioxepin-8(1H)-one
(E,E)-3beta,9beta-dihydroxy-6betaH,11betaH-13-norgermacra-1(10),4-dien-11,6-carbolactone
2alpha-hydroxy-1beta,10beta-epoxy-11betaH-eremophylan-12,8beta-olide
3beta-hydroxy-4beta,10beta-epoxy-1alpha(H),5alpha(H),11alpha-guaian-8alpha,12-olide
(E,E)-2alpha,9beta-dihydroxy-6betaH,11alphaH-13-norgermacra-1(10),4-dien-11,6-carbolactone
3,4,6-trihydroxy-eudesm-7-en-12-oic acid 6-lactone|Mibulacton
(E)-3-hydroxy-3,4,4,6-tetramethyl-7,8-dioxocyclonon-5-enyl acetate|cooliatin
1beta,6alpha-dihydroxycostic acid|1??-6??-Dihydroxycostic acid
(1S,9S)-3beta,6beta-dihydroxy-2alpha,5alpha-epoxy-4alpha,11,11,8beta-tetramethyltricyclo[5.4.0.02,5]undecan-7-one|fascicularone D
4alpha,6alpha-Dihydroxyeudesm-11(13)-en-12,8beta-olide
1beta,3alpha-dihydroxyeudesma-5,11(13)-dien-12-oic acid
2beta,11alpha-dihydroxy-eudesm-5-en-8beta,12-olide
11beta(H),13-dihydrosalonitenolide|11beta,13-dihydrosalonitenolide
(2R,7S)-7-formyloxy-2-hydroxy-12-nornardosin-1(10)-en-11-one
8alpha-hydroxy-4alpha,5beta-epoxy-11betaH-germacr-1(10)E-en-12,6-alpha-olide|desacetyllanuginolide
(3alpha,11?)-3,11-Dihydroxy-7,9-eremophiladien-8-one|6-Dehydro-11,12-dihydroxypetasol
Britannilactone
Britannilactone is a terpene lactone. (3AS,4S,7AR)-4-Hydroxy-5-[(2S)-5-hydroxypentan-2-YL]-6-methyl-3-methylidene-3A,4,7,7A-tetrahydro-1-benzofuran-2-one is a natural product found in Inula japonica with data available.
1alpha,8alpha-dihydroxygermacra-4E,9Z-dien-6beta,7alpha,11betaH-12,6-olide
(-)-(3aS,6R,6aR,8aR,9S,9aS)-decahydro-6,9-dihydroxy-6,8a-dimethyl-3-methylenecyclobuta[6,7]cycloocta[1,2-b]furan-2(3H)-one|michampanolide
10alpha-hydroxy-4H-tomentosin|4,10-Dihydroxy-4,5-seco-1(5),11(13)-guaiadien-12,8-olide
5-hydroxy-2,2,6,6-tetramethyl-4-(3-methylbutanoyl)cyclohex-4-ene-1,3-dione
1,10beta-dihydroxy-4alphaH-1,10-secoeudesma-5(6),11(13)-dien-12,8beta-olide
(3S,3aS,6S,8S,9R,9aS,9bR)-3a,4,5,6,7,8,9,9a,9b-octahydro-8,9-dihydroxy-3,6,9a-trimethylazuleno[4.5-b]furan-2(3H)-one|3beta,4beta,6beta-trihydroxy-10alphaH-11alpha-methyl-ambrosa-1-en-12-oic acid gamma-lactone|hysterone E
3-(3-hydroxybutyl)-1,1-dimethylisochroman-6,8-diol
10betaH,11betaH-7alpha,8alpha-epoxy-6beta-hydroxyeremophilan-12,8beta-olide|eremopetasitenin A4
(Z)-1beta,4alpha-dihydroxy-5alpha,8beta(H)-eudesm-7(11)-en-12,8-olide
(6S,7S)-6,7-dihydroxy-3,6-dimethyl-2-isovaleroyl-4,5,6,7-tetrahydrobenzofuran
4,8-Dihydroxy-6,6,8-trimethyl-4,4a,5,6,7,7a,8,9-octahydroazuleno[5,6-c]furan-3(1H)-one #
4beta-methoxy-9beta-acetoxy-11,12,13-trinor-5-eudesmen-7-one
(3aR,4S,5R,5aR,9aR,9bS)-1,2,3a,4,5,5a,6,7,9a,9b-decahydro-5,8-dimethyl-1-methylidenenaphto(2,1-b)furane-3a,4,9b-triol|lyophyllanetriol A
(3S,3aR,4aR,5R,7aS,9S,9aR)-decahydro-5,9-dihydroxy-3,5-dimethyl-8-methylideneazuleno[6,5-b]furan-2(3H)-one|4alpha,9alpha-dihydroxy-1betaH,11alphaH-guai-10(14)-en-12,8alpha-olide
6beta,9beta-dihydroxyeremophil-7(11)-en-(12,8alpha)-olide
(1R,4R,5S,6R,7R,8S,11S)-8,15-dihydroxyguaia-10(14)-en-6,12-olide
(6S,10S)-6,10-dihydroxy-7,8-seco-2,8-cyclo-muurol-4(5),7(11)-diene-12-oic acid
4alpha,15-dihydroxy-5alpha,8betaH-eudesman-7(11)-en-8alpha,12-olide|atractylenolide IV
1-hydroxy-1-(1-oxo-3-methyl-2-butenyl)-2-acetoxy-3,5,5-trimethyl-3-cyclopentene
1,5-epoxy-4-hydroxyguai-11(13)-en-12-oic acid|rel-(3R,3aR,5R,8S,8aR)-hexahydro-3-hydroxy-3,8-dimethyl-alpha-methylene-1H,4H-3a,8a-epoxyazulene-5-acetic acid
(4S,5R,8R,10S)-1-nor-10-hydroxy-8-methoxyeremophil-7(11)-en-12, 8-olide
(1aS,1bR,4S,4aR,5aR,6R,8aS,8bR)-decahydro-6-hydroxy-4,6,8b-trimethyloxireno[7,8]azuleno[6,5-b]furan-3(1bH)-one|9beta,10beta-epoxy-4alpha-hydroxy-1betaH,11alphaH-guaian-12,8alpha-olide
6,7,13-trihydroxy-alpha-ylang-5-one|dendronephthol C
11alphaH,13-dihydroburrodin|2alpha-hydroxy-11alpha,13-dihydroconfertin
(+)-(3R*,4aS*,8aS*)-3-[(E)-4-hydroxybut-2-en-2-yl]-5,5,8a-trimethyl-3,4,4a,5-tetrahydrobenzo[c][1,2]dioxin-6(8aH)-one|okundoperoxide
10alpha-hydroxy-10(14),11beta(13)-tetrahydrozaluzanin C
4E,10E-3beta,11beta-dihydroxygermacra-4(5),10(1)-dien-12,6alpha-olide
3,8,8-Trimethyl-4,5,8,9,10,11-hexahydrophenanthro[10,1-bc]pyran
1beta,5alpha-dihydroxy-11alphaH-eudesma-4(15)-en-12,8beta-olide|1beta-hydroxy-7alphaH,11alphaH-eudesm-4(15)-en-12,8beta-lactone
(+)-(1S,3S)-1,3-dihydroxy-gamma-ionylideneacetate|(1R.3S)-(2Z,4E)-1,3-dihydroxy-gamma-ionylideneacetic acid|(1S,2Z,3S,4E)-5-(1,3-Dihydroxy-2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-2,4-pentadienoic acid
6alpha-hydroxy-4alpha,5beta-epoxy-11alphaH-germacr-1(10)E-en-12,8alpha-olide
3beta-hydroxy-4alpha(3)-dihydrosantamarine|4alpha(15)-dihydroridentin B
3,8-Dimethyl-4a,5-dihydroxy-5-isopropyl-4a,5,8,8a-tetrahydronaphthalene-2,6(1H,7H)-dione
(3S,10S)-epoxy-1beta-hydroxy-(4Z)-germacren-12,6alpha-olide|caruifolin A
(11S)-10alpha-hydroxy-3-oxo-4betaH-guaiano-12,6alpha-lactone|(3S,3aS,6R,6aR,9S,9aR,9bS)-6-hydroxy-3,6,9-trimethyl-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-2,8(3H,9bH)-dione|10alpha-hydroxy-3-oxo-1,5,7alphaH,4,6,11betaH-guaian-6,12-olide|3-Hydroxyimino-dihydro-isophoto-alpha-santonic lacton|4alpha-methyl-dihydroisophoto-alpha-santonin lactone|dihydroisophotosantonin lactone|Dihydroisophotosantoninlacton
(11Xi)-1,6beta-dihydroxy-4-oxo-10alphaH-ambrosan-12-oic acid-6-lactone|(11Xi)-1,6beta-Dihydroxy-4-oxo-10alphaH-ambrosan-12-saeure-6-lacton|dihydrocoronopilin|tetrahydroparthenin
5-hydroxy-2,2,6,6-tetramethyl-4-(2-methylbutanoyl)cyclohex-4-ene-1,3-dione
2-heptyl-3,6-dihydroxy-4-methoxybenzaldehyde|fordianol
(1R,4S,5R,7R,8R,10S)-1,5-dihydroxyeudesma-11(13)-en-12,8-olide
Isobutyric acid 2-(1-methyl-1-methoxy-2-hydroxyethyl)-5-methylphenyl ester
(8betaOH,10beta)-8,10-Dihydroxy-7(11)-eremophilen-12,8-olide|8beta,10beta-dihydroxyeremophil-7(11)-en-8alpha,12-olide|8beta,10beta-dihydroxyeremophilenolide|8beta,10beta-dihydroxyeremophyl-7(11)-en-12,8alpha-olide
7-Tigloyl-(4R*,5R)-5,7-Dihydroxy-p-menth-1(6)-en-2-one
(1beta,6alpha)-1,6,14-trihydroxyeudesm-3-en-12-oic acid gamma-lactone|rel-(3R,3aR,5aS,6S,9aR,9bR)-3a,4,5,5a,6,7,9a,9b-octahydro-6-hydroxy-9-(hydroxymethyl)-3,5a-dimethylnaphtho[1,2-b]furan-2(3H)-one
ent-11,14-dihydroxy-3-oxo-driman-12-oic acid-11-lactone|ent-11,14-Dihydroxy-3-oxo-driman-12-saeure-11-lacton
1beta,3alpha-dihydroxy-11aH-eudesma-4(5)-en-12,8beta-olide
(3aR,3bS,4R,5aS,6aR,7S,9aS)-octahydro-4-hydroxy-1,3b,7-trimethyl-4H-oxireno[1,8a]azuleno[4,5-b]furan-2(1H)-one
(-)-(5S*,6S*,7S*,9R*,10S*)-7-hydroxy-5,7-epidioxycadinan-3-ene-2-one
1,14-dihydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide
1alpha,4alpha-dihydroxyeudesm-2-en-5alpha,6beta,7alpha,11betaH-12,6-olide|Erivanin
8alpha-hydroxy-1,4beta-epoxy-10-epieudesman-5alpha,6beta,7alpha,11betaH-12,6-olide|Shonachalin B
1(10),4(5)-dien-6alpha-hydroxy-11alpha-hydroxymethylene-6beta,8beta,11beta(H),5alpha,7alpha(H)-germacr-8,12-olide|13alpha-hydroxymethylenedeacetyllaurenobiolide
(2S,5R)-2-(2-hydroxypropan-2-yl)-5,9-dimethyl-1-oxaspiro[5.5]undec-8-ene-7,10-dione
[2-(hydroxymethyl)-3-methoxy-4-methyl-5-(3-methylbut-2-enoxy)phenyl]methanol
3a,8-dihydroxy-3,5a,9-trimethyl-4,5,6,7,8,9b-hexahydro-3H-benzo[g][1]benzofuran-2-one
3-hydroxy-4-(2-hydroxy-6-methylheptan-2-yl)benzoic acid
C12-AS (TENTATIVE)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; Extracted (without noise removal) from ZWI_N: mz265_15_rt18_47_HCD60_C12-AS; CONFIDENCE Tentative identification: best match only (Level 3)
C15H22O4_2-[(3S,3aR,5R,7aS)-3a-Acetyl-3-hydroxy-7a-methyloctahydro-1H-inden-5-yl]acrylic acid
C15H22O4_2,8-Dihydroxy-5,5,8-trimethyl-11-oxatetracyclo[7.3.1.0~1,9~.0~3,7~]tridecan-10-one
C15H22O4_3a,7-Ethano-3aH-indene-4-carboxylic acid, octahydro-6-hydroxy-3,8,8-trimethyl-2-oxo
C15H22O4_11-(Hydroxymethyl)-2,11-dimethyl-3-oxotricyclo[4.3.2.0~1,5~]undecane-9-carboxylic acid
C15H22O4_(3aS,4S,7aR)-4-Hydroxy-5-[(2S)-5-hydroxy-2-pentanyl]-6-methyl-3-methylene-3a,4,7,7a-tetrahydro-1-benzofuran-2(3H)-one
C15H22O4_Naphtho[2,3-b]furan-2(4H)-one, 4a,5,6,7,8,8a,9,9a-octahydro-9,9a-dihydroxy-3,4a,5-trimethyl-, (4aR,5S)
C15H22O4_Azuleno[5,6-c]furan-1(3H)-one, 4,4a,5,6,7,7a,8,9-octahydro-4,8-dihydroxy-6,6,8-trimethyl
C15H22O4_5,8-Dihydroxy-3,5,8-trimethyl-4a,5,6,7,7a,8,9,9a-octahydroazuleno[6,5-b]furan-2(4H)-one
C15H22O4_Naphtho[1,2-c]furan-3(1H)-one, 5,5a,6,7,8,9,9a,9b-octahydro-5-hydroxy-6-(hydroxymethyl)-6,9a-dimethyl
C15H22O4_2-[(1E,3E)-1,3-Hexadien-1-yl]-5-(3-hydroxy-2-methoxypropyl)-2-methyl-3(2H)-furanone
C15H22O4_1,9b-Dihydroxy-6,6,9a-trimethyl-5,5a,6,7,8,9,9a,9b-octahydronaphtho[1,2-c]furan-3(1H)-one
3-hydroxy-4-(2-hydroxy-6-methylheptan-2-yl)benzoic acid
1,9b-dihydroxy-6,6,9a-trimethyl-1,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-3-one
1,4-dihydroxy-6,6,9a-trimethyl-4,5,5a,7,8,9-hexahydro-1H-benzo[e][2]benzofuran-3-one
5,9-dihydroxy-5,7,7-trimethyl-4,5a,6,8,8a,9-hexahydro-1H-azuleno[5,6-c]furan-3-one
(1S,8R,9R)-8-hydroxy-4-(propan-2-ylidene)-10-oxatricyclo[7.2.1.01,5]dodecane-8-carboxylic acid
Verrucarol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
Tri-N-butyl phosphate
MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; STCOOQWBFONSKY-UHFFFAOYSA-N_STSL_0219_Tri-N-butyl phosphate_0002fmol_190326_S2_LC02MS02_076; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.
(1S,8R,9R)-8-hydroxy-4-(propan-2-ylidene)-10-oxatricyclo[7.2.1.01,5]dodecane-8-carboxylic acid_major
(4aR,5S)-9,9a-dihydroxy-3,4a,5-trimethyl-5,6,7,8,8a,9-hexahydro-4H-benzo[f][1]benzofuran-2-one_major
1,4-dihydroxy-6,6,9a-trimethyl-4,5,5a,7,8,9-hexahydro-1H-benzo[e][2]benzofuran-3-one_major
5,9-dihydroxy-5,7,7-trimethyl-4,5a,6,8,8a,9-hexahydro-1H-azuleno[5,6-c]furan-3-one_major
1,9b-dihydroxy-6,6,9a-trimethyl-1,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-3-one_major
5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl-Pentanoic acid (Gemfibrozil M1)
5-[2-(hydroxymethyl)-5-methylphenoxy]-2,2-dimethyl-Pentanoic acid (Gemfibrozil M4)
6beta,8beta-Dihydroxyeremophilenolide
3,14-Dihydroxy-11,13-dihydrocostunolide
1a,15-Dihydroxymarasmene
3a,15-Dihydroxymarasmene
(1alpha,4alpha,5beta,6alpha,11betaH)-1,4-Epoxy-5-hydroxy-10(14)-germacren-12,6-olide
1a-Hydroxyarbusculin a
7-Hydroxytrichodermol
4'-Dihydroabscisic acid
Ipomeamaronolide
1,4-Dihydroxy-6,6,9a-trimethyl-4,5,5a,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-3(1H)-one
3a,8-Dihydroxy-3,5a,9-trimethyl-3a,4,5,5a,6,7,8,9b-octahydronaphtho[1,2-b]furan-2(3H)-one
2-[[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]methyl]oxirane
2-Benzyl-2,7-diazaspiro[4.5]decane hydrochloride (1:1)
1-[(2,4,6-Trimethoxyphenyl)methyl]piperazine dihydrochloride
(E)-but-2-enedioic acid,(4E)-octa-1,4,7-triene,prop-1-ene
[2-amino-2-(3-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester
(R)-(+)-Atenolol
(R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist[1][2].
3-AMINO-3-[4-(3-DIMETHYLAMINO-PROPOXY)-PHENYL]-PROPIONIC ACID
esatenolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
[2-amino-2-(2-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester hydrochloride
2-[(1R,2R,3S,4R)-2-Formyl-4-methyl-3-(3-oxobutyl)cyclohexyl]acryl ic acid
methyl (E)-2-[(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)methyl]pent-2-enoate
TERT-BUTYL 2-(AMINOMETHYL)-4-METHOXYBENZYLCARBAMATE
(S)-1-(3-(Ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethylethanamine oxide
7-(3-hydroxy-5-oxo-1-cyclopenten-1-yl)-(5Z)--Heptenoic acid-1-Methylethyl ester
8-(2-furanyl)-8-hydroxy-(5Z) -Octenoic acid-1-Methylethyl ester
(4-((4-ethylpiperazin-1-yl)Methyl)-2-fluorophenyl)boronic acid
methyl (2R,3S)-2-ethyl-7,7-dimethyl-5-oxo-3,4,6,8-tetrahydro-2H-chromene-3-carboxylate
methyl (2S,3S)-2-ethyl-7,7-dimethyl-5-oxo-3,4,6,8-tetrahydro-2H-chromene-3-carboxylate
1-(4-METHOXY-PHENOXY)-3-PIPERAZIN-1-YL-PROPAN-2-OL
2-(1,4,5,7-Tetramethyl-pyrrolo[3,4-d]pyridazin-6-yl)-phenylamine
(1S,5R,6S,7S,8S,10R,11R)-6-hydroxy-4-oxopseudoguai-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis
Isonordoperoxide
A sesquiterpenoid that is 1,4,5,6,7,8-hexahydro-4,7-epidioxyazulen-3(2H)-one substituted by a hydroxy group at position 8, methyl groups at positions 1 and 4 and an isopropyl group at position 7 (the (1R,4R,7S,8S stereoisomer). Isolated from Nardostachys chinensis, it exhibits antimalarial activity.
(3aR,4R,6aR)-rel-dihydro-3-methylene-4-octyl-furo[3,4-b]furan-2,6(3H,4H)-dione
4H-Pyrido(1,2-a)pyrimidine-3-carboxylic acid, 1,6,7,8,9,9a-hexahydro-1-ethyl-6-methyl-4-oxo-, ethyl ester
practolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Same as: D05587 Practolol is a potent and selective β1-adrenergic receptor antagonist. Practolol can be used for the research of cardiac arrhythmias[1][2][3].
Bucolome
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
5,8-Dihydroxy-3,5,8-trimethyl-4a,5,6,7,7a,8,9,9a-octahydroazuleno[6,5-b]furan-2(4h)-one
3a,8-dihydroxy-3,5a,9-trimethyl-4,5,6,7,8,9b-hexahydro-3H-benzo[g][1]benzofuran-2-one
(2Z,4E)-5-[(1S,4S)-1,4-dihydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid
(2Z,4E)-5-[(1S,4S)-1,4-dihydroxy-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpenta-2,4-dienoic acid
2-[(3S,3aR,5R,7aS)-3a-acetyl-3-hydroxy-7a-methyl-2,3,4,5,6,7-hexahydro-1H-inden-5-yl]prop-2-enoic acid
(+)-(7S)-sydonic acid
A sesquiterpenoid that is benzoic acid substituted by a hydroxy group at position 3 and a (2S)-2-hydroxy-6-methylheptan-2-yl group at position 4. It has been isolated from the sea fan derived fungus Aspergillus sydowii.
1beta-hydroxy arbusculin A
A sesquiterpene lactone that is the 1beta-hydroxy derivative of arbusculin A. Isolated from Saussurea lappa, it exhibits inhibitory activity against melanogenesis.
(2R,3R,4S,5R)-2-({[(1R)-2-Hydroxy-1-phenylethyl]amino}methyl)-5-methylpyrrolidine-3,4-diol
11-(Hydroxymethyl)-2,11-dimethyl-3-oxotricyclo[4.3.2.01,5]undecane-9-carboxylic acid
2-[(1E,3E)-hexa-1,3-dienyl]-5-(3-hydroxy-2-methoxypropyl)-2-methylfuran-3-one
Pentanoic acid, 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl-
1-Ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol
Nardoperoxide
A sesquiterpenoid that is 1,4,5,6,7,8-hexahydro-4,7-epidioxyazulen-3(2H)-one substituted by a hydroxy group at position 8, methyl groups at positions 1 and 4 and an isopropyl group at position 7 (the (1R,4R,7R,8R stereoisomer). Isolated from Nardostachys chinensis, it exhibits antimalarial activity.
(1R,3aS,5R,5aR,8R,8aS,8bR)-1,3a,8-trihydroxy-5,8-dimethyl-2-methylidene-1,4,5,5a,6,7,8a,8b-octahydroacenaphthylen-3-one
hydron;3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine
N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide
(2E)-2-[(3R,3aR,4S,8aR)-3,4-dihydroxy-3a,6-dimethyl-3,3a,4,5,8,8a-hexahydroazulen-1(2H)-ylidene]propanoic acid
3-Methyl-4-[(4-methyl[2,2-bipyridin]-4-yl)imino]but-2-en-2-amine
(Z)-3-[[2-(4-methylpyridin-2-yl)pyridin-4-yl]methylideneamino]but-2-en-2-amine
2-[2-[2-[2-(Trimethylsilyloxy)ethoxy]ethoxy]ethoxy]ethanol
2-(Trimethylsilylmethyl)benzyl trimethylsilyl ether
Tributyl phosphate
D020011 - Protective Agents > D011837 - Radiation-Protective Agents
1-(furan-3-yl)-4-hydroxy-4,8-dimethylnonane-1,6-dione
[3R-(3alpha,3abeta,5aalpha,6alpha,9beta,9abeta,9balpha)]-Octahydro-6-hydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3H,4H)-dione
(6beta,8betaOH)-6,8-Dihydroxy-7(11)-eremophilen-12,8-olide
asperaculane G
A sesquiterpenoid that is (8aR)-1,2,3,3a,4,5,8,8a-octahydroazulene substituted by a 1-carboxyethylidene group at position 1, hydroxy groups at positions 3 and 4, and methyl groups at positions 3a and 6 (the 3R,3aR,4S,8aR-diastereomer).
2-trans-4-dihydroabscisic acid
An apo carotenoid sesquiterpenoid that is 2-trans-abscisic acid in which the keto group at position 4 has been reduced to the corresponding alcohol.
(3s,3ar,4ar,5s,6r,7ar,9as)-5,6-dihydroxy-3,5,8-trimethyl-3h,3ah,4h,4ah,6h,7h,7ah,9ah-azuleno[6,5-b]furan-2-one
(4r,6r)-4-hydroxy-4-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-3-methoxy-6-(prop-2-en-1-yl)cyclohex-2-en-1-one
(3-hydroxy-4-isopropyl-6-oxocyclohex-1-en-1-yl)methyl 2-methylbut-2-enoate
(3s,3ar,4s,6r,6as,8s,9as,9br)-4,8-dihydroxy-3,6-dimethyl-9-methylidene-decahydroazuleno[4,5-b]furan-2-one
9-hydroxy-3,5a,9-trimethyl-octahydronaphtho[1,2-b]furan-2,6-dione
5,10,15-trimethyl-4,9,13-trioxatetracyclo[10.3.0.0³,⁵.0⁸,¹⁰]pentadecan-14-one
(3s,3ar,5ar,6s,7s,9as,9bs)-6,7-dihydroxy-3,5a-dimethyl-9-methylidene-octahydro-3h-naphtho[1,2-b]furan-2-one
10-hydroxy-4,8,12-trimethyl-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
(1r,3s,5r,8r,10s,12s,15r)-5,10,15-trimethyl-4,9,13-trioxatetracyclo[10.3.0.0³,⁵.0⁸,¹⁰]pentadecan-14-one
4,6-dihydroxy-3,5a,9-trimethyl-3h,3ah,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-2-one
(3s,3as,5r,5ar,6r,9as,9bs)-5,6-dihydroxy-3,5a,9-trimethyl-3h,3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-2-one
(3r,3as,4ar,8s,8as,9as)-8,9a-dihydroxy-3,4a-dimethyl-5-methylidene-octahydronaphtho[2,3-b]furan-2-one
5-hydroxy-8-methoxy-14-methyl-1-oxacyclotetradeca-3,6,9-trien-2-one
(3r,3ar,4s,10s,11ar)-4-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,10h,11h,11ah-cyclodeca[b]furan-2,9-dione
(3s,3as,4r,11as)-4-hydroxy-3-(hydroxymethyl)-6,10-dimethyl-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-2-one
4,7-dihydroxy-3,6,10-trimethyl-3h,3ah,4h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3as,5r,5as,9r,9as,9br)-5,8-dimethyl-1-methylidene-2h,4h,5h,5ah,6h,9h,9ah-naphtho[2,1-b]furan-3a,9,9b-triol
(1s,2s,5s,6s,8s,9s,10r,11s)-8,11-dihydroxy-3,3,6,10-tetramethyl-12-oxatetracyclo[7.2.1.0²,⁵.0⁶,¹¹]dodecan-7-one
(3r,3as,4r,7r,11as)-4,7-dihydroxy-3,10-dimethyl-6-methylidene-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,5s,5ar,6r,9as,9bs)-5,6-dihydroxy-3,5a-dimethyl-9-methylidene-octahydro-3h-naphtho[1,2-b]furan-2-one
6,7,8-trihydroxy-4a,5-dimethyl-3-(propan-2-ylidene)-5,6,7,8-tetrahydro-4h-naphthalen-2-one
2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-1-benzoxocine-3,5,8-triol
5-(2-hydroxyethyl)-1,2,4,6-tetramethyl-3h-indene-1,2,7-triol
5-hydroxy-4a-(hydroxymethyl)-8-methyl-3-methylidene-octahydro-3ah-azuleno[6,5-b]furan-2-one
(1r,4s,5as,9as)-1,4-dihydroxy-6,6,9a-trimethyl-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-3-one
(3s,3as,11as)-6,10-bis(hydroxymethyl)-3-methyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,3as,7r,9s,11ar)-7,9-dihydroxy-3,10-dimethyl-6-methylidene-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
(2r,3s,4e,6e,8e,10e,12r,13r)-pentadeca-4,6,8,10,14-pentaene-2,3,12,13-tetrol
5,8-dimethyl-1-methylidene-2h,4h,5h,5ah,6h,9h,9ah-naphtho[2,1-b]furan-3a,9,9b-triol
2-[(1r,2r,5s,6r)-5-hydroxy-5-methyl-7-oxabicyclo[4.1.0]heptan-2-yl]-6-methylhept-1-ene-3,4-dione
4,5-dihydroxy-1-(hydroxymethyl)-1,7,7a-trimethyl-1ah,4h,5h,6h,7h,7bh-cyclopropa[a]naphthalen-2-one
(1s,2z,4s,7r,8s,11s,12r)-12-hydroxy-2,7,11-trimethyl-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-6-one
4,5-dihydroxy-6,6,9a-trimethyl-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-3-one
3-hydroxy-3,4a,8-trimethyl-octahydroazuleno[6,5-b]furan-2,5-dione
(3s,3ar,5ar,6r,8s,9bs)-6,8-dihydroxy-3,5a,9-trimethyl-3h,3ah,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-2-one
(3ar,4as,5s,7as,8s,9ar)-5-hydroxy-4a-(hydroxymethyl)-8-methyl-3-methylidene-octahydro-3ah-azuleno[6,5-b]furan-2-one
(1r,2r,5r,6r,9r)-2-(hydroxymethyl)-11,11-dimethyl-3-oxotricyclo[4.3.2.0¹,⁵]undecane-9-carboxylic acid
6-hydroxy-3,5a-dimethyl-2-oxo-decahydronaphtho[1,2-b]furan-9-carbaldehyde
(2z,4e)-5-[(1r,3s)-1,3-dihydroxy-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpenta-2,4-dienoic acid
(2r)-2-(2-hydroxy-4-methylphenyl)-2-methoxypropyl 2-methylpropanoate
(2r,3ar,7ar)-3,4-dihydroxy-7,7a-dimethyl-4'-methylidene-hexahydro-1h-spiro[indene-2,3'-oxolan]-2'-one
(3r,3ar,4s,5ar,6r,9as,9br)-4,6-dihydroxy-3,5a-dimethyl-9-methylidene-octahydro-3h-naphtho[1,2-b]furan-2-one
(1r,2s,3r,4s,8r,10r,13r)-2-hydroxy-3,4,13-trimethyl-11,14-dioxatetracyclo[8.3.1.0¹,¹⁰.0³,⁸]tetradecan-12-one
(4s,4ar,7as,8s)-4,8-dihydroxy-6,6,8-trimethyl-3h,4h,4ah,5h,7h,7ah,9h-azuleno[5,6-c]furan-1-one
(2e,4s)-4-hydroxy-2-methyl-5-[(1r,3s,6r,9s)-6-methyl-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]pent-2-enoic acid
6-hydroxy-9-(hydroxymethyl)-5a-methyl-3-methylidene-octahydro-3ah-naphtho[1,2-b]furan-2-one
2-methyl-1-(2,4,6-trimethoxy-3,5-dimethylphenyl)propan-1-one
(5ar,7s,9as,9bs)-7,9b-dihydroxy-6,6,9a-trimethyl-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-3-one
(2e,4s)-4-hydroxy-2-methyl-5-[(1r,3s,6r,9r)-6-methyl-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]pent-2-enoic acid
4-hydroxy-10-(hydroxymethyl)-3,6-dimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(1s,2s,4r,7e,9s,11s,12s)-9-hydroxy-4,8,12-trimethyl-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
9,10-dihydro-7,8-dime thyl-2-(1-methylethyl)phenanthren-3-ol
{"Ingredient_id": "HBIN013938","Ingredient_name": "9,10-dihydro-7,8-dime thyl-2-(1-methylethyl)phenanthren-3-ol","Alias": "NA","Ingredient_formula": "C19H22O","Ingredient_Smile": "CC1=C(C2=C(C=C1)C3=CC(=C(C=C3CC2)C(C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5602","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
